Synergistic effect of sodium butyrate and oxaliplatin on colorectal cancer

BACKGROUND: Oxaliplatin (OXA) is a chemotherapy agent commonly used in the treatment of colorectal cancer (CRC). Sodium butyrate (NaB) has an antitumor effect. METHODS: In total, 30 patients in stage III who completed 8 cycles of chemotherapy regimens were recruited for this study. The patients were...

Descripción completa

Detalles Bibliográficos
Autores principales: Shuwen, Han, Yangyanqiu, Wang, Jian, Chu, Boyang, Hu, Gong, Chen, Jing, Zhuang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763735/
https://www.ncbi.nlm.nih.gov/pubmed/36512976
http://dx.doi.org/10.1016/j.tranon.2022.101598

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763735/
https://www.ncbi.nlm.nih.gov/pubmed/36512976
http://dx.doi.org/10.1016/j.tranon.2022.101598

Ejemplares similares